嬌生JNJ
紐約證券 · USD
165.98
-1.28
(-0.77%)
盤中 08/01 01:53 (UTC+8)
08/01 01:53 (UTC+8)
嬌生JNJ
165.98
-1.28
(-0.77%)
財務數據
損益表
- 247.46
- 293.82
- 213.51
- 213.95
- 213.83
- 224.47
- 224.71
- 225.20
- 218.93
- 237.43
- -29.08
- 18.73
- -27.33
- 58.62
- -0.06
- 4.98
- 0.11
- 0.22
- -2.78
- 8.45
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 23,743,000 | 21,893,000 | 22,520,000 | 22,471,000 | 22,447,000 | 21,383,000 | 21,395,000 | 21,351,000 | 29,382,000 | 24,746,000 |
營業成本 | 7,628,000 | 7,357,000 | 7,128,000 | 6,963,000 | 6,869,000 | 6,511,000 | 6,798,000 | 6,606,000 | 9,920,000 | 8,395,000 |
營業毛利 | 16,115,000 | 14,536,000 | 15,392,000 | 15,508,000 | 15,578,000 | 14,872,000 | 14,597,000 | 14,745,000 | 19,462,000 | 16,351,000 |
營業費用 | 9,305,000 | - | - | - | - | 8,963,000 | 10,404,000 | 9,211,000 | 11,979,000 | 9,880,000 |
研發費用 | 3,516,000 | 3,225,000 | 5,298,000 | 4,952,000 | 3,440,000 | 3,542,000 | 4,480,000 | 3,447,000 | 3,937,000 | 3,563,000 |
推銷及管理費用 | 5,789,000 | 5,112,000 | 6,453,000 | 5,478,000 | 5,681,000 | 5,257,000 | 5,810,000 | 5,400,000 | 7,897,000 | 6,138,000 |
非經常性項目費用 | - | 17,000 | 59,000 | 41,000 | 181,000 | 164,000 | 114,000 | 364,000 | 145,000 | 179,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 6,810,000 | 6,182,000 | 3,582,000 | 5,037,000 | 6,276,000 | 5,909,000 | 4,193,000 | 5,534,000 | 7,483,000 | 6,471,000 |
其他收入及費用 | - | 7,653,000 | 442,000 | -1,506,000 | -258,000 | -2,040,000 | 784,000 | -125,000 | 178,000 | -6,993,000 |
利息費用 | 308,000 | 204,000 | 137,000 | 193,000 | 270,000 | 155,000 | 151,000 | 192,000 | 349,000 | 215,000 |
稅前純益 | 6,491,000 | 13,631,000 | 3,887,000 | 3,338,000 | 5,748,000 | 3,714,000 | 4,826,000 | 5,217,000 | 7,312,000 | -737,000 |
所得稅 | 954,000 | 2,632,000 | 456,000 | 644,000 | 1,062,000 | 459,000 | 694,000 | 908,000 | 1,745,000 | -669,000 |
稅後純益 | 5,537,000 | 10,999,000 | 3,431,000 | 2,694,000 | 4,686,000 | 3,255,000 | 4,049,000 | 26,028,000 | 5,144,000 | -68,000 |
基本每股稅後盈餘(元) | 2.30 | 4.57 | 1.43 | 1.12 | 1.95 | 1.35 | 1.68 | 10.32 | 1.98 | -0.03 |
稀釋每股稅後盈餘(元) | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 | 1.77 | 10.02 | 1.96 | -0.03 |
基本平均股數(千股) | 2406779.00 | 2405625.00 | 2406922.00 | 2407200.00 | 2406800.00 | 2408200.00 | 2407200.00 | 2522900.00 | 2598400.00 | 2605500.00 |
稀釋平均股數(千股) | 2419100.00 | 2423800.00 | 2427100.00 | 2427900.00 | 2422000.00 | 2430100.00 | 2430700.00 | 2549700.00 | 2625700.00 | 2605500.00 |
還原基本每股稅後盈餘(元) | 2.30 | 4.57 | 1.43 | 1.12 | 1.95 | 1.35 | 1.68 | 10.32 | 1.98 | -0.03 |
還原稀釋每股稅後盈餘(元) | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 | 1.34 | 1.77 | 10.02 | 1.96 | -0.03 |
還原基本平均股數(千股) | 2,406,779 | 2,405,625 | 2,406,922 | 2,407,200 | 2,406,800 | 2,408,200 | 2,407,200 | 2,522,900 | 2,598,400 | 2,605,500 |
還原稀釋平均股數(千股) | 2,419,100 | 2,423,800 | 2,427,100 | 2,427,900 | 2,422,000 | 2,430,100 | 2,430,700 | 2,549,700 | 2,625,700 | 2,605,500 |
EBITDA(千元) | 8,742,000 | 15,607,000 | 5,920,000 | 5,377,000 | 7,800,000 | 5,684,000 | 6,737,000 | 28,957,000 | 9,172,000 | 1,358,000 |